NRCHealthcare · Health Information ServicesThe 1 Wall Street analysts covering NRC Health hold a median 12-month price target of $26 — +24.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 93 of 100 as at 17 Sept 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores NRC Health on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (91): The shares have been drifting up relative to others.
Growth (36): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on NRC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +24.6% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 29 July 2026 | Citizens | Maintains | Market Outperform | $23 → $26 |
| 22 June 2026 | Citizens | Initiates | Market Outperform | $23 |
| 22 June 2026 | Citizens | Initiates | Market Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NRC appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 17 Sept 2026, NRC Health returned +36.6% against +17.0% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 8% of US stocks
Cheaper than 36% of US stocks
Cheaper than 2% of US stocks
Cheaper than 13% of US stocks
Higher than 36% of US stocks
Higher than 12% of US stocks
Higher than 75% of US stocks
Higher than 32% of US stocks
Higher than 58% of US stocks
Higher than 91% of US stocks
Higher than 88% of US stocks
Higher than 63% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
NRC Health has a market value of $487.7M and an enterprise value of $574.9M.
Revenue in the twelve months to 30 June 2026: $140.0M. The latest quarter grew 4.0% year on year.
Net income over the same four quarters: $5.9M, a 4.2% net margin.
Diluted earnings per share, trailing twelve months: $0.25.
Free cash flow in the twelve months to 30 June 2026: $21.6M.
NRC Health spent $18.8M on share buybacks and $12.7M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 91.9×; forward P/E: 21.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.97%, paying out 250% of earnings.
NRC Health employs 357 people — $392K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own NRC Health — and when they’d sell — is the membership. See the Ticker Nerd 20 →
The article highlights growing momentum in the nuclear fuel chain, noting that the nuclear renaissance requires a fuel supply infrastructure capable of supporting reactor development companies' ambitions.
Why it matters — A strengthening nuclear fuel chain suggests increased demand for uranium fuel and related services, which are central to the nuclear sector broadly.
Mercy, one of only three large U.S. health systems, received NRC Health's 2026 Excellence in Patient Experience Award, marking its fifth consecutive year earning the national honor.
Why it matters — The recognition reflects ongoing validation of NRC's patient-experience measurement and award program within large health systems.
NRC Health announced the winners of its 2026 awards program, recognizing hospitals, health systems, medical groups, and specialty providers for excellence in patient experience, consumer loyalty, innovation, and patient-centered care.
Why it matters — The annual awards highlight NRC Health's role in measuring and promoting healthcare consumer loyalty and patient experience, reinforcing its brand and industry visibility.
NRC Health's shares fell 8% even as its Q2 earnings per share rose year over year, driven by higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.
Why it matters — NRC watchers would see this as a mixed signal: the underlying business grew on recurring revenue and bookings strength, but the stock declined and rising operating expenses weighed on results.
NRC Health held its Q2 2026 earnings call, with the transcript published by Seeking Alpha. The call covered the company's financial results and operational performance for the quarter.
Why it matters — The earnings call transcript provides NRC watchers with management's perspective on the company's recent financial performance and strategic outlook.
The 1 Wall Street analysts covering NRC Health have a median 12-month price target of $26, with estimates ranging from $26 to $26. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 1 analysts covering NRC Health, 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks NRC Health 93 out of 100 across roughly 4,600 US stocks as at 17 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 17 Sept 2026, NRC Health ranks 93 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (91 of 100).
No one can know that. What the data says: the median 12-month target from 1 analysts implies +24.6% from the last close, and Ticker Nerd's factor model ranks NRC Health 93 out of 100 as at 17 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering NRC Health publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NRC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $26 to $26 over the next 12 months.
NRC Health returned +36.6% over the 12 months to 17 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
NRC Health is a healthcare experience management company headquartered in Lincoln, Nebraska. It provides software, analytics, and recurring service programs that help hospitals, health systems, medical groups, and other care organizations understand and improve the experiences of patients, consumers, and employees.
The most recent item we track (ETF Trends, 14 Sept 2026): "New Momentum in the Nuclear Fuel Chain". The article highlights growing momentum in the nuclear fuel chain, noting that the nuclear renaissance requires a fuel supply infrastructure capable of supporting reactor development companies' ambitions.
NRC Health is a healthcare experience management company headquartered in Lincoln, Nebraska. It provides software, analytics, and recurring service programs that help hospitals, health systems, medical groups, and other care organizations understand and improve the experiences of patients, consumers, and employees. The company’s current offerings include patient experience measurement, consumer and market insights, online reputation management, employee engagement tools, and governance support for healthcare leaders. NRC Health also delivers benchmarking, segmentation, and workflow solutions designed to help organizations track perceptions, identify service gaps, and align care delivery with community needs. Its platform is used across the healthcare industry to support patient engagement, loyalty, workforce experience, and performance improvement through data-driven insight and human-centered care.
CEO Mr. Trent S. Green · 357 employees · United States · https://www.nrchealth.com
